Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating Tobacco Dependence in Smokers With Severe Mental Illness
NCT03822416Phase 2Completed
- Sponsor
- University of Minnesota
- Start
- Mar 2019
- Primary completion
- May 2020
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nicotine patch in tobacco dependence (2 arms), sponsored by University of Minnesota. Primary endpoint: 7-Day Point Prevalence Abstinence at 6 months. Started Mar 2019; status: completed.
02
Drugs
nicotine patch
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT03822416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03822416.